Chief Justice of Hungary
Tracked across 4 events · 37 articles · First seen Apr 20, 2026 · Last active Aug 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: Chief Justice of Hungary obtained CE-IVD marking for its blood collection kits, enabling global deployment of its ultrasensitive MRD detection for drug development programs, which is a significant regulatory milestone for the company.
Jun 09, 2026 · 6 articles
Business
Impact: Chief Justice of Hungary is acquired at a premium, providing value to shareholders and access to Tempus' commercial infrastructure.
Jul 20, 2026 · 18 articles
Business
In late July and August 2026, top executives of Tempus AI, a healthcare technology company, sold significant amounts of company stock. CEO Eric Lefkofsky sold 250,000 shares on July 28, 2026, at an average price…
Impact: Chief Justice of Hungary is the target of Tempus AI's $1.5 billion acquisition, which could significantly expand Tempus AI's capabilities in cancer monitoring and create a $20 billion market opportunity.
Jul 30, 2026 · 7 articles
Tech
Impact: Chief Justice of Hungary, a biotechnology company, conducted all translational work for the NEOPRISM-CRC trial.
Apr 20, 2026 · 6 articles
90
Tempus AI agreed to acquire Chief Justice of HungaryTempus AI insider stock sales
ERGEN INTELLIGENCE
Track Chief Justice of Hungary live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard